Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Avingtrans Plc | AVG | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 400.00 | 08:00:22 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 400.00 | 400.00 | 400.00 | 400.00 |
| Industry Sector |
|---|
| INDUSTRIAL ENGINEERING |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 25/09/2024 | Final | GBP | 0.029 | 07/11/2024 | 08/11/2024 | 20/12/2024 |
| 28/02/2024 | Interim | GBP | 0.018 | 23/05/2024 | 24/05/2024 | 21/06/2024 |
| 27/09/2023 | Final | GBP | 0.028 | 26/10/2023 | 27/10/2023 | 08/12/2023 |
| 22/02/2023 | Interim | GBP | 0.017 | 11/05/2023 | 12/05/2023 | 16/06/2023 |
| 28/09/2022 | Final | GBP | 0.026 | 27/10/2022 | 28/10/2022 | 09/12/2022 |
| 23/02/2022 | Interim | GBP | 0.016 | 12/05/2022 | 13/05/2022 | 17/06/2022 |
| 29/09/2021 | Final | GBP | 0.04 | 28/10/2021 | 29/10/2021 | 10/12/2021 |
| Top Posts |
|---|
Posted at 14/11/2024 17:15 by cockerhoop Just had a look on the tender website. It appears there is a current open engagement for 3m3 boxes - perhaps to find a further supplier. Metalcraft unlikely to be awarded the full £800m.AVG have picked up this contract. |
Posted at 22/8/2024 08:24 by zho Excellent answer - thank you.>>Saying that group EPS and therefore PE is a pretty rubbish way to value AVG as they always have companies in a turnaround status>> Yes, understood - what I didn't realise on an initial look was that investment in medical imaging was going to be quite so significant. Will continue digging. |
Posted at 22/8/2024 08:17 by cockerhoop zho,The reduction in FY25 profitability relates to the heavy investment required in the medical imaging division as they prepare for volume production at both Adaptix and Magnetica. So whilst the underlying engineering businesses continue to be profitable the MI business will be loss making in FY25 suppressing the EPS. Saying that group EPS and therefore PE is a pretty rubbish way to value AVG as they always have companies in a turnaround status. I think it should be valued on a sum of parts basis. |
Posted at 22/8/2024 07:11 by zho Has anyone got access to earnings estimates?AVG made 23.4p in FY23 and 11.7p in H1 24, so I was puzzled by Paul Hill's tweet after the 19/6/ TU – unless his 6p is a typo and he meant 26p? “Cavendish have ... FY25 adjusted EBITDA and EPS of £14.0m & 6p respectively on revenues of £161m.” |
Posted at 23/6/2024 09:54 by cockerhoop As far as i'm aware Paul Hill isn't invested in AVG, just that they are a Vox Markets client so he interviews the two Steve's.I think PE is not a great way to value AVG as it's not a steady state business. There are always loss making subsidiaries that are in turnaround or in the case of the medical imaging businesses pre-revenue or almost pre-revenue. Sum of parts is probably the way to go. Historically the share price has moved up in steps on the sale of businesses. Booths may be the next business sold, now nicely profitable with a large orderbook in regulated markets. The large HS2 order is yet to enter production. Probably worth circa £25m which would be a great return for something bought from the administrators for peanuts. |
Posted at 22/6/2024 14:15 by earwacks The general consensus is Avg is worth around £4.40 as it is, probably more with this ahead of expectations update and nothing priced in for Adaptix or Magnetica. There is investment required in the launch of these products. They suggested a couple of companies they bought to turn around are ready for sale and there is a very valuable plot of land they have been trying to dispose of. I suppose there is a question of how soon they can release some cash to invest in the medical products. Generally though this is a company with a phenomenal track record of proven success |
Posted at 28/2/2024 11:41 by earwacks Yes they were that good. The acquisitions cost them 13 million last year. Someone on Stockopedia said about Adaptix not being able to attract any other offers. Firstly Avg already had 10 percent of the business and secondly they invited them to find a better offer. This is what Avg are renowned for, taking over businesses that have potential but cash strapped, building the business up to profitability and selling it on. It doesn’t happen over night. The nuclear waste business is booming and still no competitors in a sector they can barely service on their own . The cancelled rail works has not affected them at all and think there will be additional work there. The applications and potential for Adaptix and Magnetica are not even fully realised yet, way beyond just medical. I agree health authorities are under pressure, but actually these products could well help reduce workloads as time saving potential is huge. On the veterinary side , there will be no such problem as pet spend ever increases. Their markets are mostly in areas that are not cyclical, they are essential. Of course their is capital required in these projects. That is the mainstay of their business. Buy companies cheap, invest and sell |
Posted at 28/2/2024 08:21 by alter ego when is the dividend to be paid - couldn't see it |
Posted at 11/2/2024 20:43 by cerrito I have been catching up on these given the recent price drop to see if I should buy more but will keep my hands in my pockets.That said, uncomfortable being out of these as say the sale of Booth would give them a comfortable rerating although we will need to show continued patience ref monetizing the HT Luton site. I agree that a good deal of potential in Medical but even with the current shareprice drop,basic eps of last year's continuing and discontining earnings is approx 23x. Of course with both Cavendish and Singer forecasting an adjusted eps of 2.8p for this current FY the PE even at current prices becomes extreme. I note Cavendish have a TP at 495p and for Singer it is 510p. I am comfortable we will get to these prices in 2025. I also note the issue of high receivables, the 1.2 PC approx dividend yield and no share buybacks in the offing and their lack of interest in shareholders like me. . |
Posted at 09/2/2024 20:57 by cockerhoop Those forecasts are ballpark as the company now owns Adaptix and a larger slice of Magnetica which will both be loss making this year as AVG invests towards commercialisation of their 3d x-ray and MRI products.I accept the UK market is probably not mature enough to look beyond the PE ratio but it really isn't the best way to value companies like AVG. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
